This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has major subject area list
|
Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Prostatic Neoplasms, Castration-Resistant; Radium
|
|
information resource reference
|
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial. Eur J Cancer. 2019 06; 114:107-116.
|
|
label
|
Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.
|